What Health Information is Needed to Improve the Vaccination Outcomes of COVID-19? : Study Analysis in COVID-19 Vaccination in Sangihe Island Regency, Indonesia
Keywords:Health Information, Vaccination for COVID-19, COVID-19, Sangihe Island
AbstractThe Indonesian government enforces a COVID-19 vaccination policy for all, but the achievement rate for the COVID-19 vaccination in Sangihe Islands Regency at the first dose is only 1.05%, while the achievement at the second dose to date is only 0.47%. With this in mind, the vaccination policy has not been in line with community participation. The purpose of this study was to find out what kind of health information is needed to increase the covid-19 vaccination rate. The method used in this research is a descriptive study with a purposive sampling technique which was held from 7 January to 8 February 2021 with a total sample of 85 respondents who are health workers in the Sangihe Islands Regency. The data analysis used is descriptive analysis with frequency distribution. The results in this study were 15.3% stated that they were not willing to vaccinate COVID-19 because 39% of COVID-19 survivors, 38% had comorbidities, 15% were unsure of safety and 8% feared side effects. The conclusion of this study is to increase health information regarding vaccines for COVID-19 survivors, information about comorbidities such as what is appropriate for COVID-19 vaccination, safety, and side effects resulting from the COVID-19 vaccine.
WHO. Data Table WHO Coronavirus (COVID-19) [Internet]. 2021 [cited 2021 Apr 29]. Available from: https://covid19.who.int/
Menkumham RI. Perpres Ri Nomor 14 Tahun 2021. 2021;2019(084421):84421–30.
Keputusan Presiden RI. Keppres No 12 Tahun 2O2O Tentang Penetapan Bencana Nonalam Penyebaran Corona Virus Disease 2019 Sebagai Bencana Nasional. Fundam Nurs. 2020;(01):1–2.
Akbar I. Vaksinasi Covid-19 dan Kebijakan Negara: Perspektif Ekonomi Politik. J Acad Praja. 2021;4(1):244–54.
Kementerian Kesehatan Republik Indonesia. Question ( Faq ) Pelaksanaan Vaksinasi Covid-. 2021;1–16. Available from: https://kesmas.kemkes.go.id/assets/uploads/contents/others/FAQ_VAKSINASI_COVID__call_center.pdf
Kementerian Kesehatan Republik Indonesia. Vaksinasi COVID-19 (Data per Tanggal 29 April 2021 pukul 12.00 WIB) [Internet]. 2021 [cited 2021 Apr 29]. Available from: https://vaksin.kemkes.go.id/#/provinces
Ritchie H, Ortiz-Ospina E, Beltekian D, Mathieu E, Hasell J, Macdonald B, et al. Statistics and Research Coronavirus (COVID-19) Vaccinations [Internet]. Our World in Data. 2021 [cited 2021 May 17]. Available from: https://ourworldindata.org/covid-vaccinations?country=OWID_WRL
Chew NWS, Cheong C, Kong G, Phua K, Ngiam JN, Tan BYQ, et al. An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination. Int J Infect Dis [Internet]. 2021;106:52–60. Available from: https://doi.org/10.1016/j.ijid.2021.03.069
Kementerian Kesehatan Republik Indonesia, ITAGI, WHO, UNICEF. Survei Penerimaan Vaksin COVID-19 di Indonesia. Satuan Gugus Tugas Penanganan COVID-19. 2020;(November):1–26.
Ruiz JB, Bell RA. Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey. Vaccine. 2021 Feb 12;39(7):1080–6.
Pramardika DD. Buku Ajar Promosi Kesehatan. Makasar: Yayasan Barcode; 2020.
Kurniati DPY. Buku Ajar Perencanaan Dan Evaluasi Program. Jurnal. 2016;40 hal.
Lazarus J V., Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med [Internet]. 2021;27(2):225–8. Available from: http://dx.doi.org/10.1038/s41591-020-1124-9
PAPDI. Rekomendasi PAPDI Tentang Pemberian Vaksinasi Covid-19 [Internet]. papdi.or.id. 2020 [cited 2021 Apr 29]. Available from: https://www.papdi.or.id/berita/info-papdi/998-rekomendasi-papdi-tentang-pemberian-vaksinasi-covid-19
Wib J, Ika O. Covid-19 Tidak Divaksin. 2021.
Kementerian Kesehatan Republik Indonesia. Kelompok Komorbid bisa Divaksinasi, Begini Ketentuannya [Internet]. 2021 [cited 2021 Apr 29]. Available from: https://www.kemkes.go.id/article/view/21021800001/kelompok-komorbid-bisa-divaksinasi-begini-ketentuannya.html
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669–77.
Jain V, Yuan JM. Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection. medRxiv. 2020.
Shi Y, Yu X, Zhao H, Wang H, Zhao R, Sheng J. Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan. Crit Care. 2020;24(1).
Satria RMA, Tutupoho RV, Chalidyanto D. Analisis Faktor Risiko Kematian dengan Penyakit Komorbid Covid-19. J Keperawatan Silampari. 2020;4(1).
KPCPEN. Vaksinasi COVID-19: Lampu Hijau untuk Kelompok Komorbid dan Penyintas [Internet]. Komisi Penanganan CoOVID-19 dan Pemulihan Ekonomi Nasional. 2021 [cited 2021 Apr 29]. Available from: https://covid19.go.id/berita/vaksinasi-covid-19-lampu-hijau-untuk-kelompok-komorbid-dan-penyintas
Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla AE, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. Vol. 13, Journal of Infection and Public Health. Elsevier Ltd; 2020. p. 1833–9.
Rengganis I. Vaksinasi COVID-19 [Internet]. Jakarta; 2021. Available from: https://www.papdi.or.id/pdfs/999/Prof Iris Rengganis - Vacc COVID-19 Workshop 18 Januari 2021.pdf
Ahyad MRM. Analisa Penyebaran Berita Hoax Di Indonesia. Jurnal [Internet]. 2017;16. Available from: http://ravii.staff.gunadarma.ac.id/Publications/files/3552/ANALISIS+PENYEBARAN+BERITA+HOAX++DI+INDONESIA.pdf
Juditha C. Interaksi Komunikasi Hoax di Media Sosial Serta Antisipasinya. J Pekommas. 2018;3(1):31–4.
Allegrante JP, Auld ME, Natarajan S. Preventing COVID-19 and Its Sequela: “There Is No Magic Bullet. It’s Just Behaviors.” Am J Prev Med [Internet]. 2020;59(2):288–92. Available from: https://doi.org/10.1016/j.amepre.2020.05.004
Kemenkes. Buku Saku.Pdf [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2020. Available from: https://dinkes.jatimprov.go.id/userimage/dokumen/Buku Saku.pdf
BPOM RI. Keamanan dan Efikasi Vaksin Covid-19. 2021;14. Available from: https://persi.or.id/wp-content/uploads/2021/01/paparan_bppom_rakernassus.pdf
WHO. Background paper on COVID-19 vaccines Prepared by the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 vaccines. EuropeanreviewOrg [Internet]. 2020;(February):1–52. Available from: https://covid19.who.int/table
How to Cite
All articles submitted by the author and published in the Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, are fully copyrighted by the publication of Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan under the Creative Commons Attribution-NonCommercial 4.0 International License by technically filling out the copyright transfer agreement and sending it to the publisher
The author can include in separate contractual arrangements for the non-exclusive distribution of rich versions of journal publications (for example: posting them to an institutional repository or publishing them in a book), with the acknowledgment of their initial publication in this journal.
Authors are permitted and encouraged to post their work online (for example: in an institutional repository or on their website) before and during the submission process because it can lead to productive exchanges, as well as earlier and more powerful citations of published works. (See Open Access Effects).